CAPZB
F-actin-capping protein subunit beta
Also known as: CAPZB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P47756
- Gene
- CAPZB
- Ensembl
- ENSG00000077549
- Chromosome
- 1
- Canonical length
- 272 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes the beta subunit of the barbed-end actin binding protein, which belongs to the F-actin capping protein family. The capping protein is a heterodimeric actin capping protein that blocks actin filament assembly and disassembly at the fast growing (barbed) filament ends and functions in regulating actin filament dynamics as well as in stabilizing actin filament lengths in muscle and nonmuscle cells. A pseudogene of this gene is located on the long arm of chromosome 2. Multiple alternatively spliced transcript variants encoding different isoforms have been found.[provided by RefSeq, Aug 2013]
Canonical amino-acid sequenceUniProt
272 residues, UniProt reviewed canonical sequence.
>P47756|CAPZB
1 MSDQQLDCAL DLMRRLPPQQ IEKNLSDLID LVPSLCEDLL SSVDQPLKIA RDKVVGKDYL
61 LCDYNRDGDS YRSPWSNKYD PPLEDGAMPS ARLRKLEVEA NNAFDQYRDL YFEGGVSSVY
121 LWDLDHGFAG VILIKKAGDG SKKIKGCWDS IHVVEVQEKS SGRTAHYKLT STVMLWLQTN
181 KSGSGTMNLG GSLTRQMEKD ETVSDCSPHI ANIGRLVEDM ENKIRSTLNE IYFGKTKDIV
241 NGLRSVQTFA DKSKQEALKN DLVEALKRKQ QCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAPZB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 276 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 276 nTPM
- blood vessel: 258 nTPM
- tonsil: 255 nTPM
- colon: 246 nTPM
- smooth muscle: 223 nTPM
- thymus: 221 nTPM
Single-cell type
- late spermatids: 6,076 nCPM
- hofbauer cells: 1,600 nCPM
- early spermatids: 1,378 nCPM
- esophageal apical cells: 1,196 nCPM
- neutrophils: 1,100 nCPM
- megakaryocytes: 1,014 nCPM
Immune cell
- eosinophil: 1,079 nTPM
- non-classical monocyte: 706 nTPM
- total PBMC: 596 nTPM
- neutrophil: 578 nTPM
- intermediate monocyte: 542 nTPM
- basophil: 458 nTPM
Brain region
- white matter: 141 nTPM
- hippocampal formation: 132 nTPM
- thalamus: 128 nTPM
- medulla oblongata: 121 nTPM
- hypothalamus: 113 nTPM
- pons: 112 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.91
- gnomAD missense Z
- 2.83
- DepMap mean gene effect
- -1.05
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin polymerization or depolymerization
- barbed-end actin filament capping
- cytoskeleton organization
- lamellipodium assembly
- regulation of cell morphogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- F-actin-capping protein subunit alpha/beta
- F-actin-capping protein subunit alpha/beta, domain 2
- F-actin-capping protein subunit beta
- F-actin capping protein, beta subunit, conserved site
- F-actin-capping protein subunit beta, N-terminal domain
- F-actin capping protein, beta subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CAPZB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAPZB as an antibody target. Whether an autoantibody or antibody against CAPZB could matter depends on whether native CAPZB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAPZB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CAPZB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...